Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1 076,13
-15,38
-1,41%
—1 091,511 090,401 090,401 073,69——
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1 248,82
+10,84
+0,88%
—1 237,981 237,831 252,411 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 724,36
-20,35
-1,17%
—1 744,711 740,951 747,291 721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3 263,41
+2,72
+0,08%
—3 260,693 273,363 287,813 240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1 462,56
-4,24
-0,29%
—1 466,801 464,701 467,191 458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2 380,40
-17,10
-0,71%
—2 397,502 395,032 412,012 370,64——
EKSO:NASDAQ
Ekso Bionics Holdings Inc
11,80 $
+0,08%
(+0,010) 1D
11,87 $
+0,56% (+0,066)
After hours
Closed: 4 մյս, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EKSO...
Open
11,65 $
High
11,80 $
Low
10,56 $
Mkt. cap
42,05 մլն
Avg. vol.
55,47 հզր
Volume
95,45 հզր
52-wk high
13,50 $
52-wk low
2,73 $
EPS
-4,91 $
Beta
0,86
Shares outstanding
3,56 մլն
No. of employees
50
News stories
From sources across the web
Profile
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk. Ekso Bionics currently focuses in the health and industrial sectors. The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
About Ekso Bionics Holdings Inc
CEOScott Davis
Employees50
Founded2005
HeadquartersՍան Ռաֆայել, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websiteeksobionics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
2,06 մլն
4,23 մլն
3,14 մլն
2,14 մլն
Cost of goods sold
1,24 մլն
1,68 մլն
1,47 մլն
1,07 մլն
Cost of revenue
1,24 մլն
1,68 մլն
1,47 մլն
1,07 մլն
Research and development expenses
852,00 հզր
550,00 հզր
31,00 հզր
583,00 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,94 մլն
3,40 մլն
5,40 մլն
6,11 մլն
Operating expense
4,79 մլն
3,95 մլն
5,43 մլն
6,69 մլն
Total operating expenses
6,03 մլն
5,63 մլն
6,90 մլն
7,76 մլն
Operating income
-3,98 մլն
-1,40 մլն
-3,76 մլն
-5,62 մլն
Other non operating income
-8,00 հզր
-5,00 հզր
20,00 հզր
-740,00 հզր
EBT including unusual items
-2,71 մլն
-1,42 մլն
-4,67 մլն
-6,88 մլն
EBT excluding unusual items
-2,71 մլն
-1,42 մլն
-3,92 մլն
-6,74 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,71 մլն
-1,42 մլն
-4,67 մլն
-6,88 մլն
Net profit margin
-131,70%
-33,62%
-148,85%
-321,58%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-65,00 հզր
-18,00 հզր
-155,00 հզր
-143,00 հզր
Net interest expenses
-65,00 հզր
-18,00 հզր
-155,00 հզր
-143,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,60 մլն
-1,04 մլն
-3,31 մլն
-5,16 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer